RareCyte Investor
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.
Technology:
Metabolic Disorders
Industry:
PharmTech
Headquarters:
Seattle, Washington, United States
Founded Date:
2009-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership